» Articles » PMID: 15722411

Modulation of CD1d-restricted NKT Cell Responses by Using N-acyl Variants of Alpha-galactosylceramides

Overview
Specialty Science
Date 2005 Feb 22
PMID 15722411
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

A form of alpha-galactosylceramide, KRN7000, activates CD1d-restricted Valpha14-invariant (Valpha14i) natural killer (NK) T cells and initiates multiple downstream immune reactions. We report that substituting the C26:0 N-acyl chain of KRN7000 with shorter, unsaturated fatty acids modifies the outcome of Valpha14i NKT cell activation. One analogue containing a diunsaturated C20 fatty acid (C20:2) potently induced a T helper type 2-biased cytokine response, with diminished IFN-gamma production and reduced Valpha14i NKT cell expansion. C20:2 also exhibited less stringent requirements for loading onto CD1d than KRN7000, suggesting a mechanism for the immunomodulatory properties of this lipid. The differential cellular response elicited by this class of Valpha14i NKT cell agonists may prove to be useful in immunotherapeutic applications.

Citing Articles

Can invariant Natural Killer T cells drive B cell fate? a look at the humoral response.

Palacios P, Santibanez A, Aguirre-Munoz F, Gutierrez-Vera C, Nino de Zepeda-Carrizo V, Gongora-Pimentel M Front Immunol. 2025; 16:1505883.

PMID: 40040714 PMC: 11876049. DOI: 10.3389/fimmu.2025.1505883.


State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues.

Praveena T, Le Nours J Front Immunol. 2024; 15:1479382.

PMID: 39669569 PMC: 11635198. DOI: 10.3389/fimmu.2024.1479382.


The iNKT cell ligand α-GalCer prevents murine septic shock by inducing IL10-producing iNKT and B cells.

Park Y, Lee S, Kim T, Park H, Van Kaer L, Hong S Front Immunol. 2024; 15:1457690.

PMID: 39355237 PMC: 11442275. DOI: 10.3389/fimmu.2024.1457690.


Boosting Immunogenicity of a Recombinant Strain via Zinc-Dependent Ribosomal Proteins.

Singh S, Kanzin D, Chavez S, Saavedra-Avila N, Ng T, Lukose R Biomedicines. 2024; 12(7).

PMID: 39062144 PMC: 11274837. DOI: 10.3390/biomedicines12071571.


Stereospecific Synthesis and Biological Evaluation of KRN7000 Analogues with Thio-modifications at the Acyl Moiety.

Hao T, Mi T, Chu Q, Ma W, Cheng X, Zang Y ACS Med Chem Lett. 2024; 15(7):1102-1108.

PMID: 39015265 PMC: 11247626. DOI: 10.1021/acsmedchemlett.4c00199.


References
1.
Sonoda K, EXLEY M, Snapper S, Balk S, Stein-Streilein J . CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med. 1999; 190(9):1215-26. PMC: 2195676. DOI: 10.1084/jem.190.9.1215. View

2.
Sidobre S, Naidenko O, Sim B, Gascoigne N, Garcia K, Kronenberg M . The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol. 2002; 169(3):1340-8. DOI: 10.4049/jimmunol.169.3.1340. View

3.
Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, Nakui M . alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol. 2000; 199(1):37-42. DOI: 10.1006/cimm.1999.1602. View

4.
Eberl G, MacDonald H . Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol. 2000; 30(4):985-92. DOI: 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E. View

5.
Matsuda J, Naidenko O, Gapin L, Nakayama T, Taniguchi M, Wang C . Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med. 2000; 192(5):741-54. PMC: 2193268. DOI: 10.1084/jem.192.5.741. View